. home.aspx

home.aspx
   

A Field Manual For The Battle Over HIV Prevention Drug Pricing

August 29, 2019 / ROCHELLE P. WALENSKY A. DAVID PALTIEL

Pre-exposure prophylaxis (PrEP) an HIV prevention intervention consisting of a daily drug cocktail, quarterly HIV/sexually transmitted disease screening, and laboratory monitoring—has repeatedly been shown to be safe, effective, and cost-effective. Although US guidelines have recommended PrEP for all high-risk individuals since 2014, fewer than 200,000 of the 1.2 million eligible Americans are enrolled in a PrEP program. The burden of inadequate coverageis borne disproportionately by the nation’s most vulnerable communities.